Skip to main content
Skip to "About this site"
Canada.ca
Services
Departments
Language selection
Français
Search and menus
Search and menus
Patented Medicine Prices Review Board
Search
Search website
Search
[ENGLISH_LABEL_SITEMENU]
Legislation
Act and Regulations
Compendium of Policies, Guidelines and Procedures
Rules of Practice and Procedures for Hearings
Regulatory Management
Regulating Prices
Regulatory Process
Scientific Review
Price Review
Investigations
Advance Ruling Certificates
VCUs
Hearings
The Hearing Process
Status of Ongoing Proceedings
Decisions and Orders
Rules of Practice and Procedures for Hearings
Reporting
Reports and Trends
Pharmaceutical Trends
Annual Reports
NPDUIS
About NPDUIS
Analytical Studies
Research Agenda
NPDUIS Advisory Committee
You are here:
Home
View comments received from Stakeholders
Comments Received
Abbott Laboratories Limited (October 22, 2007) (
PDF
)
AstraZeneca Canada Inc. (October 22, 2007) (
PDF
)
BIOTECanada (October 19, 2007) (
PDF
)
Bristol-Myers Squibb Canada Co. (October 22, 2007) (
PDF
)
Eli Lilly Canada Inc. (October 22, 2007) (
PDF
)
Hoffmann-La Roche Limited (October 19, 2007) (
PDF
)
GlaxoSmithKline (GSK), (October 22, 2007) (
PDF
)
Procter & Gamble Pharmaceuticals Canada Inc. (October 22, 2007) (
PDF
)
Rx&D (October 22, 2007) (
PDF
)
Schering-Plough Canada Inc. (October 31, 2007) (
PDF
)
Wyeth Pharmaceuticals (October 22, 2007) (
PDF
)
Date modified:
2014-09-16
Secondary menu